AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 352 businesses audited.
Healthcare Providers & Medical Clinics BS: alife.jp (Palliative Prognosis Prediction Tools) (alife.jp)
A rare example of a ‘Zero-BS’ medical utility site. It functions as a pure technical tool for clinicians, prioritizing medical accuracy and practical utility over any form of marketing or patient acquisition.
Implement Organization and Person schema to formally link the site to the Japanese medical societies mentioned. Add specific doctor names and their medical registration numbers to the ‘About’ section to verify the ‘operated by doctors’ claim. Include a formal privacy policy or data protection statement given that it is a tool used in a clinical setting, even if no data is collected.
The information density is exceptionally high for a web property. Headings are entirely functional nouns such as PaP Score, PPI, and PiPS-B, with zero power-word saturation. The body text consists of technical medical parameters like Karnofsky Performance Scale, white blood cell counts, and specific survival probability calculations (14-day and 56-day survival probabilities), representing a high ratio of substance over fluff.
AI systems don't validate syntax — they validate identity, relationships, and meaning. Get a Clinical Structured Data Diagnosis to reveal what AI sees versus what it should see.
There is zero semantic drift across the analyzed pages. The homepage H1 ‘Prognosis Prediction for Palliative Medicine’ and the meta description promising easy-to-use mobile tools are directly fulfilled by the sub-pages which contain interactive calculators. The site’s purpose as a clinical utility for medical professionals is maintained consistently without shifting to patient-facing marketing or generic services.
Stop the ROI leak caused by technical debt and strategic misalignment. Conduct an Independent Strategic Diagnosis for 1 Euro to identify high impact issues across all audit categories.
The site contains no trust theatre elements; review_count and trust_theatre_flag are zero across all pages. Rather than using patient testimonials, the site relies on academic citations, such as the H5 reference to ‘Support Care Cancer 1999; 7: 128-33’ on the PPI page. The lack of social proof is a positive indicator here as it avoids the generic ‘trusted by thousands’ industry cliché.
Proof density is high, focused on academic and clinical validation rather than commercial social proof. The site references specific guidelines (Bone Metastasis Clinical Practice Guidelines) and provides direct citations for the scoring systems used. Each technical tool is accompanied by its limitations and the logic behind its scoring (e.g., subjective vs. objective factors), providing a level of transparency rarely seen in medical marketing.
To see how the system reconstructs a medical entity graph at scale, review the full Cleveland Clinic Structured Data audit. View the Cleveland Clinic Structured Data Audit for a live example of identity level decomposition and cross page entity mapping.
The site has a zero-match rate for industry clichés like ‘world-class healthcare’ or ‘compassionate care.’ The value proposition is highly unique: it solves a specific technical friction point (unit conversion for PiPS-B for Japanese clinical values). No template fingerprints like ‘Why Choose Us’ or ‘Our Services’ are present, and the content could not be copy-pasted onto a competitor’s site without possessing the same technical calculation logic.
The primary authority gap is the lack of specific practitioner names and registration numbers, though it claims to be operated by members of the Japan Society of Anesthesiologists. There is no schema_json (null) to provide structured identity for the organization or the individuals involved. This creates a technical credibility gap despite the high substance of the content itself.
There are no marketing-led performance claims to disconnect from. The site makes functional claims about its tools (e.g., ‘BPS3 has higher prediction accuracy’ and ‘PiPS A is not recommended for clinical use due to low accuracy’) which are presented as technical warnings rather than sales points. This reinforces the site’s role as a clinical reference rather than a commercial entity.
Healthcare Providers & Medical Clinics BS: alife.jp (Palliative Prognosis Prediction Tools) (alife.jp)
The site fits the Healthcare Providers & Medical Clinics category, specifically as a clinical decision support tool for palliative care. It avoids general healthcare consumer marketing in favor of technical medical utility for practitioners.
Every retrieval failure begins with one root cause: the model cannot segment the page correctly. Read the Semantic HTML Technical Guide to learn how structural clarity prevents chunk collapse and embedding noise.
“The score of 12 is driven almost entirely by the lack of structured data (Schema) and the absence of named individual credentials (Identity & Authority). All other pillars scored near zero BS due to the high density of technical medical substance and lack of generic marketing language.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 26, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at alife.jp (Palliative Prognosis Prediction Tools) to view the most current version of their content and see directly what the company offers.
